Kora Healthcare Team2022-01-24T10:23:59+00:00January 24th, 2022|
SELENASE - KORA HEALTHCARE APPOINTED SELENASE MARKETING AUTHORISATION HOLDER Dublin, Ireland, 24 January 2022. Biosyn Arzneimittel GmbH and Kora Healthcare concluded an exclusive licensing agreement for the continued supply and commercialisation of selenase ® (sodium selenite pentahydrate) in the United Kingdom for the treatment of
Kora Healthcare Team2021-10-04T16:07:19+01:00October 4th, 2021|
Kora Healthcare, an emerging Dublin-based pharma company, today announced it has acquired Chifam Inc, a Canadian-based speciality pharma company focussed on immunotherapy and immune modulation. The acquisition of Chifam Inc by Kora Healthcare is via its Canadian entity Kora Healthcare Canada Inc. No deal terms
Kora Healthcare Team2021-05-04T15:07:06+01:00May 4th, 2021|
Kora Healthcare are delighted to be announced as Winner of the Exporter of the Year award in the SFA National Small Business Awards 2021! The SFA Awards celebrate the achievements of small businesses in Ireland and recognises the important and vital contributions of this sector
Kora Healthcare Team2018-03-27T11:09:38+01:00January 31st, 2018|
Kora Healthcare are currently recruiting for a number of positions both in our Head Office in Dublin and Out UK office in York. If you are interested in joining our team, please get in touch. We are an emerging company committed to identifying, developing and
Kora Healthcare Team2018-03-27T11:10:02+01:00September 8th, 2017|
Kora Healthcare nominated for Export Achievement Award at 2017 Pharma Industry Awards. The shortlist for the 2017 Pharma Industry Awards has been announced and Kora Healthcare are thilled to recieve a nomination for the Export Achievement Award . The winner will be announced at the
